Nicholas Glover - 14 Nov 2025 Form 4 Insider Report for Lite Strategy, Inc. (MEIP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Nov 2025, 13:41:38 UTC
Prior SEC filing
17 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nicholas Glover

Key filing fact

Nicholas Glover filed Form 4 for Lite Strategy, Inc. (MEIP) on 19 Nov 2025.

Key facts

  • This page summarizes Nicholas Glover's Form 4 filing for Lite Strategy, Inc. (MEIP).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 19 Nov 2025, 13:41.

Change

  • Previous filing in this sequence was filed on 17 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001578888 Primary reporting owner

Glover Nicholas

Relationship
Director
Address
C/O LITE STRATEGY, INC, 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO
Signature
/s/ Nicholas Glover
Signature date
19 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LITS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+55,000
Change %
Price
Shares after
55,000
Date
14 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
55,000
Exercise price
$2.02
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026.

Footnote F2

Received as compensation for service on the Board.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .